196 results on '"Lax, Sigurd F."'
Search Results
2. A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors
3. Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
4. Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes
5. Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance
6. ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer
7. The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance
8. Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories
9. Correction to: Screening for colorectal cancer
10. Früherkennung, Diagnostik, Bildgebung und Pathologie
11. Malignant phyllodes tumor of the breast with axillary lymph node metastasis: case report and review of the literature
12. Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESP
13. Papillary lesions of the breast
14. Data Set for the Reporting of Carcinomas of the Vagina: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
15. Clinical-Pathological Conference Series from the Medical University of Graz: Case No 164: A 46-year-old man with abdominal pain, dyspnea and rapidly progressing multiorgan failure
16. Systemische Auswirkungen und klinische Aspekte der SARS-CoV-2-Infektion
17. Praktische Aspekte von COVID-19-Obduktionen
18. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
19. Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage
20. Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors
21. Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
22. Clinical Behavior and Molecular Landscape of Stage I p53-abnormal Low-Grade Endometrioid Endometrial Carcinomas
23. Classification of Endometrial Carcinoma
24. Pathology of Endometrial Carcinoma
25. Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma
26. A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer
27. Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases
28. ♀ Mixed Epithelial and Mesenchymal Tumors of the Uterus
29. ♀ Mesenchymal Tumors of the Female Genital Tract
30. A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer
31. The central role of the pathologist in the management of patients with cervical cancer: ESGO/ESTRO/ESP guidelines
32. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
33. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
34. Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
35. Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
36. The clinical, morphological, and genetic heterogeneity of endometrial stromal sarcoma
37. Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma
38. Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
39. Dataset for the Reporting of Gestational Trophoblastic Neoplasia: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
40. Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
41. Data Set for the Reporting of Carcinomas of the Vulva: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
42. Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
43. Dataset for the Reporting of Carcinoma of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
44. Can the classification of low-grade endometrial stromal tumors still be improved?
45. Pathology of Endometrial Carcinoma
46. Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53mutation status, but p53 expression/TP53status lack prognostic significance
47. Miniseries of reviews: gynecological pathology
48. Papillary lesions of the breast
49. OpenQKD Use-case for Securing Sensitive Medical Data at rest and in transit
50. Virchows Archiv / Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.